Robyn T Rebbeck Selected Research

Catecholamines

1/2024	ent-Verticilide B1 inhibits type 2 ryanodine receptor channels and is antiarrhythmic in Casq2-/- mice.
12/2019	Unnatural verticilide enantiomer inhibits type 2 ryanodine receptor-mediated calcium leak and is antiarrhythmic.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robyn T Rebbeck Research Topics

Disease

6	Heart Failure 10/2023 - 01/2019
4	Heart Diseases (Heart Disease) 02/2023 - 12/2019
3	Cardiac Arrhythmias (Arrythmia) 01/2024 - 12/2019
2	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2023 - 01/2021
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2024
1	Non-alcoholic Fatty Liver Disease 01/2023
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2023
1	Brain Ischemia (Cerebral Ischemia) 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2021
1	Muscular Diseases (Myopathy) 01/2020
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2020
1	Muscular Dystrophies (Muscular Dystrophy) 01/2020
1	Epilepsy (Aura) 12/2019

Drug/Important Bio-Agent (IBA)

5	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2024 - 01/2019
2	CatecholaminesIBA 01/2024 - 12/2019
2	verticilideIBA 10/2023 - 12/2019
2	SpectrinIBA 01/2023 - 01/2021
1	Amyloid beta-PeptidesIBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Calcium-Calmodulin-Dependent Protein KinasesIBA 12/2021
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 12/2021
1	DystrophinIBA 01/2020

Therapy/Procedure

4	Therapeutics 02/2023 - 01/2020